Menu UF Health Home Menu
 

Clinical Trials

Introduction

Test-TubeChoosing to participate in a clinical trial is an important decision. The following frequently asked questions provide introductory information about clinical trials. It is also helpful to talk to a physician, family members, or friends about deciding to join a trial. The decision to enter a clinical trial or not is always up to you. Anything you decide will, of course, be personal and will depend upon your interests, needs, and expectations about research. After identifying some trial options, the next step is to contact the study research staff and ask questions about specific trials.

The Clinical Trial Volunteer’s Bill of Rights

Points to Remember

  • Clinical trials are tests of medical treatments to see if they are safe and if they work.
  • Before you agree to take part in a study, you must be given complete information about the study, including possible side effects and benefits.
  • You must sign a special agreement called “Informed Consent” before taking part in the study.
  • You can leave the study at any time.

Current Trials

An Open-Label Study to Evaluate the Efficacy and Safety of the Neuronetics NeuroStar TMS Therapy® System in Patients with Major Depressive Disorder (MDD) with PostPartum Onset:

  • Seeking women 18-50 years old.
  • Onset of Postpartum within 6 months of live birth, baby can be no older than 9 months at enrollment.
  • Participants are compensated visits.
  • Principal Investigator: Richard Holbert, M.D.
  • If interested contact Dana Mason at 352-273-8540 or e-mail at dmason@ufl.edu.

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) (with the H-ADD Coil) intended as an aid to Smoking Cessation:

  • 22-70 years of age.
  •  Current, chronic, heavy (>10 cigarettes/day) smokers, who have smoked for more than 1 year, with no period of abstinence for greater than 3 months during the past year.
  •  Participants are compensated for visits.
  • Principal Investigator: Herbert Ward, M.D.
  • If interested contact Dana Mason at 352-273-8540 or e-mail at dmason@ufl.edu.

Controlled Trial of Deep Brain Stimulation for treatment-resistant OCD:

  • 22-75 years old.
  • Treatment-resistant OCD (have failed multiple medications and Cognitive-Behavioral Therapy).
  • Principal Investigator: Herbert Ward, M.D.
  • If interested contact Dana Mason at 352-273-8540 or e-mail at dmason@ufl.edu.

SPRITES: Sertraline Pediatric Registry for the Evaluation of Safety-A non-interventional, longitudinal, cohort study to evaluate the effects of long-term sertraline treatment in children and adolescents:

  • Children ages 6-16.
  • Provided a new prescription for sertraline within 45 days of enrollment in SPRITES for the treatment of depression, OCD, social phobia, or generalized anxiety.
  • Participants are compensated for visits.
  • Principal Investigator: Regina Bussing, M.D.
  • If interested contact Dana Mason at 352-273-8540 or e-mail at dmason@ufl.edu.

Contact Us

Department of Psychiatry
1149 S. Newell Drive
Mc Knight Brain Institute
Suite L4-100
Gainesville, FL 32611
Phone: (352) 294-4900
Fax: (352) 392-2579